Bronx MBCT-Migraine

Bronx Mindfulness Based Cognitive Therapy for Migraine: a Randomized Clinical Trial

This randomized clinical trial aims to examine the effect of a standardized 8-week course of Mindfulness Based Cognitive Therapy for Migraine on migraine-related disability in people with migraine.

Inclusion Criteria:

• ICHD-3 beta headache diagnosis of migraine,
• self-reported and diary-confirmed 4-20 headache days per month
• aged 18-65
• ability to read English
• capacity to consent.

Exclusion Criteria:

• no ICHD-3 beta headache diagnosis of migraine
• fewer than 4 or greater than 20 headache days per month
• under 18 or over 65
• inability to read English
• lacking the capacity to consent
• utilization of new preventative pain treatments within four weeks of the baseline assessment, or a plan to utilize new preventive pain medications during the duration of the study
• severe psychiatric illness that would interfere with participation in the treatment